Tables
- TABLE 1
Clinical outcome of Pseudomonas aeruginosa eradication
Pre-eradication Post-eradication p-value# FEV1 % predicted median (range) 68 (54–82) 74 (59–89) 0.549 Exacerbation frequency 0.011 No exacerbations 6 (10%) 16 (27%) One exacerbation 19 (32%) 17 (28%) Two or more exacerbations 35 (58%) 27 (45%) Hospital admissions 1.000 No exacerbations 40 (67%) 40 (67%) One or more exacerbation(s) 20 (33%) 20 (33%) FEV1: forced expiratory volume in 1 s. #: 12 months pre-eradication versus 12 months post-eradication, analysed with paired t-test for continuous variables and Chi-squared test for categorical variables. Bold indicates statistically significant p-values.
Vol 53 Issue 4
Table of Contents
The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre
